These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7880176)

  • 21. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345.
    Fong TM; Cascieri MA; Yu H; Bansal A; Swain C; Strader CD
    Nature; 1993 Mar; 362(6418):350-3. PubMed ID: 8384323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonists that demonstrate species differences in neurokinin-1 receptors.
    Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
    Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected].
    Gether U; Nilsson L; Lowe JA; Schwartz TW
    J Biol Chem; 1994 Sep; 269(39):23959-64. PubMed ID: 7929043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of tritium standard gas by the use of tritiated methane.
    Kushita K; Takeuchi N; Hoizumi K
    Radioisotopes; 1985 Jan; 34(1):1-6. PubMed ID: 4001450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synthesis of 3,3-diethylpiperid-2-one.
    Baker JA; Harper JF
    J Chem Soc Perkin 1; 1967; 21():2148. PubMed ID: 6070190
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation of ethyl diphenamate in ethanol using potassium diphenimide and 2-chloroethanol.
    Knevel AM; Wells JN
    J Pharm Sci; 1970 Dec; 59(12):1844-5. PubMed ID: 5499730
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preparation and characteristics of a tritiated derivative of CP-96,345--a nonpeptide antagonist of the substance P receptor with a high specific radioactivity].
    Kasheverov IE; Zaĭtsev DA; Utkin IuN; Tsetlin VI
    Bioorg Khim; 1994 Nov; 20(11):1162-8. PubMed ID: 7880176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
    Chahl LA; Johnston PA
    Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
    [No Abstract]   [Full Text] [Related]  

  • 31. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
    Schmidt AW; McLean S; Heym J
    Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites.
    Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ
    Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation.
    Karlsson U; Näsström J; Berge OG
    Regul Pept; 1994 Jun; 52(1):39-46. PubMed ID: 7972930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist.
    MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND
    Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.